Italian Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €91.0b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Regeneron Pharmaceuticals

Market Cap: €66.6b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Agilent Technologies

Market Cap: €36.9b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Bayer

Market Cap: €52.4b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Jazz Pharmaceuticals

Market Cap: €15.3b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Qiagen

Market Cap: €8.3b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Iovance Biotherapeutics

Market Cap: €1.9b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Evotec

Market Cap: €913.6m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Organon

Market Cap: €3.6b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

Geron

Market Cap: €872.5m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €213.6m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Orion Oyj

Market Cap: €10.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Zoetis

Market Cap: €31.4b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Gilead Sciences

Market Cap: €163.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Viatris

Market Cap: €19.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bristol-Myers Squibb

Market Cap: €118.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Exelixis

Market Cap: €14.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

SCHOTT Pharma KGaA

Market Cap: €2.6b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Roche Holding

Market Cap: €271.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

IQVIA Holdings

Market Cap: €34.6b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Roche Holding

Market Cap: €271.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

TG Therapeutics

Market Cap: €7.6b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Bruker

Market Cap: €9.4b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Swedish Orphan Biovitrum

Market Cap: €165.7b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Arterra Bioscience

Market Cap: €21.3m

A research-based biotech company, engages in the research and development of various ingredients and natural solutions.

Ionis Pharmaceuticals

Market Cap: €13.5b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Thermo Fisher Scientific

Market Cap: €194.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Grifols

Market Cap: €5.5b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Tecan Group

Market Cap: €2.2b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Novartis

Market Cap: €234.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Pfizer

Market Cap: €138.6b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Amgen

Market Cap: €201.9b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Medpace Holdings

Market Cap: €15.9b

Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

Madrigal Pharmaceuticals

Market Cap: €12.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Illumina

Market Cap: €28.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.